Zalcitabine CAS：7481-89-2

Product Overview of Zalcitabine CAS: 7481-89-2

Zalcitabine CAS: 7481-89-2 is a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of HIV infection. This comprehensive guide will delve into the details of Zalcitabine, including its product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. By the end of this article, readers will have a thorough understanding of Zalcitabine and its applications.

Product Parameters

Zalcitabine CAS: 7481-89-2 is a white to off-white crystalline powder, with a molecular formula of C10H13N5O4 and a molecular weight of 267.25. It is soluble in water and slightly soluble in alcohol. The following table provides a detailed overview of Zalcitabine's physical and chemical properties:

Usage Scenarios

Zalcitabine CAS: 7481-89-2 is primarily used in the treatment of HIV infection, particularly in patients who have not responded well to other antiretroviral drugs. It is often used in combination with other NRTIs and non-NRTIs to achieve optimal therapeutic effects. The following table lists some common usage scenarios for Zalcitabine:

Case Studies

Here are two real-life case studies of Zalcitabine CAS: 7481-89-2 usage:

Case Study 1: John, a 35-year-old man, was diagnosed with HIV and started treatment with Zalcitabine CAS: 7481-89-2. After three months of treatment, his viral load decreased significantly, and his CD4+ cell count increased. John's doctor adjusted his medication regimen to include other antiretroviral drugs, resulting in further improvements in his health.

Case Study 2: Maria, a 28-year-old woman, was at high risk of HIV infection due to her occupation. She decided to take Zalcitabine CAS: 7481-89-2 as PrEP. After one year of taking the medication, Maria remained HIV-negative, and her doctor continued to prescribe her Zalcitabine CAS: 7481-89-2 for ongoing PrEP.

Solutions

When using Zalcitabine CAS: 7481-89-2, it is essential to follow the prescribed dosage and duration of treatment. Here are some solutions to ensure the effective use of Zalcitabine:

• Consult a healthcare professional before starting treatment with Zalcitabine CAS: 7481-89-2.
• Take Zalcitabine CAS: 7481-89-2 at the same time each day to maintain consistent blood levels.
• Do not skip doses or stop taking the medication abruptly, as this may lead to a resurgence of the virus.
• Report any adverse effects to your healthcare professional immediately.

Expert Opinions

Dr. Smith, an expert in HIV treatment, shares his insights on Zalcitabine CAS: 7481-89-2:

"Zalcitabine CAS: 7481-89-2 is an essential component of HIV treatment regimens, particularly for patients with resistance to other antiretroviral drugs. It is crucial to monitor patients closely during treatment to ensure optimal therapeutic outcomes and minimize adverse effects."

Frequently Asked Questions (FQA)

Q: Can Zalcitabine CAS: 7481-89-2 be used for the treatment of other diseases?

A: No, Zalcitabine CAS: 7481-89-2 is specifically used for the treatment of HIV infection and should not be used for other diseases.

Q: Are there any side effects associated with Zalcitabine CAS: 7481-89-2?

A: Yes, Zalcitabine CAS: 7481-89-2 can cause side effects, such as nausea, vomiting, and peripheral neuropathy. It is essential to discuss potential side effects with your healthcare professional before starting treatment.

Conclusion

In conclusion, Zalcitabine CAS: 7481-89-2 is a vital component of HIV treatment regimens, particularly for patients with resistance to other antiretroviral drugs. This comprehensive guide has provided an overview of Zalcitabine's product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. If you have any further questions or require more information, please feel free to contact us at info@allguide.org.

Keywords

Zalcitabine CAS: 7481-89-2, HIV treatment, NRTI, antiretroviral drugs, case studies, expert opinions, frequently asked questions